Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to present an engaging and interactive course to improve the professional knowledge and skills for cardiovascular pharmacotherapy in older patients.
The course will be held in London on 25 October 2019.
In Europe and the Western World in particular, the proportion of older persons is dramatically increasing, which is predicted to add tremendous extra pressure to the strained health care systems.
Cardiovascular drugs are among the most prevalent drugs administered to older people. In particular diuretics, antihypertensives, NOACs, antiarrhythmics, lipid lowering drugs and glucose lowering drugs. All these drug classes can lead to increased frailty and should in particular not be prescribed on a one-size-fits-all-basis to older people, and polypharmacy should be countered.
Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better, personalized therapy of older people, which in turn will have a positive impact on services and patient outcomes.
09:00 Welcome: introduction and course objectives
Thomas A Schmidt, Keld Kjeldsen, Heinz Drexel, Juan Carlos Kaski
09:10 – 10:10 SESSION 1: GENERAL ASPECTS
Chairpersons: H Drexel and B Lewis
20min - Demographical developments and feasibility of treating older patients in a short stay unit- “The Elderly” trial.
20min - Drug metabolism in older people - J. Tamargo
20min - Discussion
10:10 – 10:40 SESSION 2: DIURETICS
Chairpersons: J Tamargo and S Agewall
20min - Case presentation and discussion - The problem of Hypo- and hyperkalemia in older people - K Kjeldsen
10:40 – 11:00 Refreshments and networking
11:00 – 11:30 SESSION 3: ANTIHYPERTENSIVES – Optimal management of hypertension in older people
Chairpersons: G Rosano and B Lewis
30min Case presentation: Anti-hypertensive treatment in older patients - Teck Khong
11:30 – 12:00 SESSION 4: NOACs in the elderly
Chairpersons: Irina Savelieva and James Uprichard
30min Case presentation: The use of NOACs in older (speaker tbc)
12:00 – 13:00 Lunch and networking
13:00 – 13:30 SESSION 5: ANTIARRHYTHMICS
Chairperson: G Savarese and S Wassmann
30min Case presentations – Therapeutic decisions – Manav Sohal
13:30 – 14:00 SESSION 6: LIPID LOWERING DRUGS
Chairpersons: H Drexel and Paul Collinson
30min - Case presentation (tbc)
14:00 – 14:30 SESSION 7: GLUCOSE LOWERING DRUGS – Debate
Chairpersons: Arshia Panahloo, G Rosano and Kenneth Earle
15min - Tight glycemic control is necessary – PRO: H Drexel
15min - Tight glycemic control is necessary – CONTRA: T A Schmidt
14:30 – 15:00 Refreshments and networking
15:00 – 15:30 SESSION 8: ANTIPLATELET MANAGEMENT AFTER PRIMARY PCI and STEMI
Chairpersons: JC Kaski and A Ferro
30min - Guidelines & beyond: S Wassman
15:30 – 15:50 WORKSHOP ON POLYPHARMACY – PLENARY SESSION
Chairpersons: J Tamargo and T A Schmidt
20min Problems with polypharmacy in older people – J Tamargo
15:50 – 16:30 Cases and discussion
16:30 – 16:45 Closing remarks: H Drexel – T A Schmidt – JC Kaski
Registration will open soon.
Juan Carlos Kaski, MD, DSc, FESC
Thomas A Schmidt, MD, DSc, FESC
Keld Kjeldsen, MD, DSc
Heinz Drexel, MD, DSc, FESC
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
London, United Kingdom
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved